Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever(Imperial College London), Björn Dahlöf(Sahlgrenska University Hospital), Neil R Poulter(Imperial College London), Hans Wedel(Nordic School of Public Health), Gareth Beevers(Birmingham City Hospital), Mark J. Caulfield(Queen Mary University of London), Rory Collins(University of Oxford), Sverre E. Kjeldsen(Ullevål Sykehusapotek), Arni Kristinsson(Reykjavík University), Gordon T. McInnes(University of Glasgow), Jesper Mehlsen(Frederiksberg Hospital), Markku S. Nieminen(Helsinki University Hospital), Eoin OʼBrien(Beaumont Hospital), Jan Östergren(Karolinska University Hospital)
The Lancet
April 1, 2003
Cited by 3,792

Abstract


Related Papers

No related papers found

Powered by citation graph analysis